• June 3-6, 2024
  • San Diego Convention Center, California



From Chasing My Cure to Every Cure: Dr. David Fajgenbaum on the Power of AI to Repurpose Medicines

Wednesday, June 05, 2024
Super Session
Patient Advocacy
This inspiring session features a presentation and moderated Q&A with Dr. David Fajgenbaum, the Co-Founder & President of Every Cure, which was recently awarded a $48.3 million contract from ARPA-H to utilize AI to revolutionize the future of repurposing existing drugs to serve new patient populations. David Fajgenbaum, MD, MBA, MSc, will share his inspiring story going from being a medical student to a patient battling a deadly disease which he discovered a repurposed treatment for that is saving his life and others. Now a physician-scientist at the University of Pennsylvania and one of the youngest professors to receive tenure in the history of Penn Medicine, Dr. Fajgenbaum is also co-Founder & President of the Castleman Disease Collaborative Network (CDCN), co-Founder & President of Every Cure, and national bestselling author of ‘Chasing My Cure: A Doctor’s Race to Turn Hope Into Action‘. Through his work at the University of Pennsylvania’s Center for Cytokine Storm Treatment & Laboratory, CDCN, and Every Cure, he has identified and/or advanced 16 other treatments for diseases they weren’t initially intended for. He recently co-Founded Every Cure to unlock the full potential of FDA-approved medicines to treat every disease possible and is pioneering a new field termed computational pharmacophenomics that utilizes AI to predict the most promising drug repurposing opportunities and validates them in clinical trials. Dr. Fajgenbaum also serves on the Board of Directors for the Reagan-Udall Foundation for the FDA. One of the youngest awardees of multiple top NIH and FDA grants, Fajgenbaum has published scientific papers in high-impact journals such as the New England Journal of Medicine, Journal of Clinical Investigation, and The Lancet, been recognized with awards such as the 2016 Atlas Award which he received along with then Vice President Joe Biden and the 2021 NDRI Service to Science Award along with Nobel Laureates Katalin Kariko and Drew Weissman, and been profiled in a New York Times cover story as well as by Good Morning America, CNN, Forbes 30 Under 30, and the Today Show. Dr. Fajgenbaum earned a BS from Georgetown University, MSc from the University of Oxford, MD from the University of Pennsylvania, and MBA from The Wharton School.
David Fajgenbaum, MD, MBA, MSc
Associate Professor of Medicine (Translational Medicine and Human Genetics)
University of Pennsylvania, Perelman School of Medicine
Back to Session List


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.